Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

AstraZeneca

Main focus: Many different therapeutic areas including oncology, cardiovascular, neurological diseases and others

Company stage: Commercial

Diseases: Undisclosed

Genome editing technology: CRISPR-Cas9

Funding stage: Public (NASDAQ:AZN)

Location: Cambridge, England

Website: https://www.astrazeneca.com/

Pipeline: https://www.astrazeneca.com/our-therapy-areas/pipeline.html

AstraZeneca is a public, clinical-stage big pharma company focused on a wide array of therapeutic areas. AstraZeneca has worked with CRISPR-based therapeutic models on several occasions. The company demonstrated the use of CRISPR to reverse a mutation causing enzyme deficiency in an α1-antitrypsin-deficient mouse model. The company is also working closely with several global laboratories to develop new CRISPR tools such as CRISPR GUARD, CRISPR VIVO and DISCover-seq.

Tags

HashtagAstraZeneca

Company: AstraZeneca
close
Search CRISPR Medicine